582pGBX-1.00p (-0.17%)
easyJet plc operates as a low-cost airline carrier in Europe.
easyJet plc in the Industrials sector is trading at 582p with a market capitalization of $3.6B. Wall Street consensus targets 458p (16 analysts), implying a -21.3% move over the next 12 months. The stock is currently near its 52-week high of 621p, remaining 29.3% above its 200-day moving average. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (GBP) · Annual | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue | £5.77B↓ | £8.17B↓ | £9.31B↓ | £10.11B |
| Gross Profit | £801.00M↓ | £1.38B↓ | £1.56B↓ | £1.70B |
| Operating Income | -£27.00M↓ | £453.00M↓ | £597.00M↓ | £703.00M |
| Net Income | -£169.00M↓ | £324.00M↓ | £452.00M↓ | £494.00M |
easyJet plc operates as a low-cost airline carrier in Europe. The company engages in the development of building projects; financing and insurance business; and tour operator activities, as well as provides holiday packages. It also offers heavy base...
British no-frills airline EasyJet rejected Thursday a fourth informal takeover proposal from a US private equity firm, but left the door open to possible talks on a higher offer. Under the proposal, Castlelake and its co-investors would own 49 percent of the airline.
The move marks a shift in easyJet’s stance toward Castlelake, which as recently as Monday called out the airline’s unwillingness to engage meaningfully.
The price target story around easyJet has shifted, with fair value in updated models moving from £5.78 to £4.48 and fresh targets now clustering around £5.70. That change reflects a split analyst backdrop, where some research houses are lifting targets into the £5.40 to £5.70 range while others hold to lower levels near £4.05, £3.00 or £2.80. As you read on, you will see how this evolving narrative is being built and what to watch if you are tracking easyJet closely. Stay updated as the Fair...
↗️ AbbVie (ABBV): The pharmaceutical company agreed to buy Apogee Therapeutics (APGE) for about $10.9 billion. AbbVie shares advanced more than 6%, while the biotech company's stock shot up more than 46%.
Castlelake’s £4.74 billion bid is testing whether easyJet shareholders want cash now or the full upside of a turnaround still taxiing toward takeoff.